KYMR
Price
$65.98
Change
+$1.71 (+2.66%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
4.81B
77 days until earnings call
Intraday BUY SELL Signals
SEER
Price
$1.89
Change
-$0.01 (-0.53%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
106M
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs SEER

Header iconKYMR vs SEER Comparison
Open Charts KYMR vs SEERBanner chart's image
Kymera Therapeutics
Price$65.98
Change+$1.71 (+2.66%)
Volume$7.37K
Capitalization4.81B
Seer
Price$1.89
Change-$0.01 (-0.53%)
Volume$855
Capitalization106M
KYMR vs SEER Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. SEER commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and SEER is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (KYMR: $64.32 vs. SEER: $1.90)
Brand notoriety: KYMR and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 43% vs. SEER: 73%
Market capitalization -- KYMR: $4.81B vs. SEER: $106M
KYMR [@Biotechnology] is valued at $4.81B. SEER’s [@Biotechnology] market capitalization is $106M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and SEER are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 2 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 2 bearish.
  • SEER’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than SEER.

Price Growth

KYMR (@Biotechnology) experienced а -2.60% price change this week, while SEER (@Biotechnology) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

SEER is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.81B) has a higher market cap than SEER($106M). KYMR YTD gains are higher at: 59.881 vs. SEER (-17.814). SEER has higher annual earnings (EBITDA): -82.75M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. SEER (210M). SEER has less debt than KYMR: SEER (24.8M) vs KYMR (85.7M). KYMR has higher revenues than SEER: KYMR (44.7M) vs SEER (16M).
KYMRSEERKYMR / SEER
Capitalization4.81B106M4,539%
EBITDA-267.03M-82.75M323%
Gain YTD59.881-17.814-336%
P/E RatioN/AN/A-
Revenue44.7M16M279%
Total Cash665M210M317%
Total Debt85.7M24.8M346%
TECHNICAL ANALYSIS
Technical Analysis
KYMRSEER
RSI
ODDS (%)
Bearish Trend 6 days ago
76%
Bullish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
84%
Bullish Trend 6 days ago
82%
Momentum
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 6 days ago
71%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
SEER
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWAX91.88N/A
N/A
American Funds New World R1
ASMMX32.02N/A
N/A
Invesco Summit A
MSECX11.15N/A
N/A
Morgan Stanley Inst International Eq C
LVAEX29.92N/A
N/A
LSV Value Equity Investor
BSGSX15.76N/A
N/A
Baird Small/Mid Cap Growth Investor

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.80%
NRIX - KYMR
62%
Loosely correlated
-3.31%
VERA - KYMR
60%
Loosely correlated
+12.88%
KURA - KYMR
55%
Loosely correlated
-2.53%
CGON - KYMR
53%
Loosely correlated
-4.35%
IDYA - KYMR
52%
Loosely correlated
-1.75%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
-0.08%
AXON - SEER
56%
Loosely correlated
+0.91%
ARRY - SEER
47%
Loosely correlated
-0.13%
KYMR - SEER
36%
Loosely correlated
-3.80%
VCYT - SEER
35%
Loosely correlated
-0.43%
IDYA - SEER
33%
Loosely correlated
-1.75%
More